San Diego-based Viking Therapeutics marked by itself as a significant competitor in the weight loss drug sector in February after revealing promising info from the mid-stage trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when offered for a weekly injection As well as in March the company unveile